6550-- Cancer Diagnosis Probes

The Department of Veterans Affairs Veterans Health Administration (VA) is seeking to procure specialized FISH probes and reagents for the VA Greater Los Angeles Healthcare System's cytogenetics department through solicitation number 36C26225Q0840. The procurement focuses on next-generation sequence testing probes for diagnosing various cancer types, including Myeloproliferative Neoplasms, Myelodysplastic Syndromes, Acute Myeloid Leukemia, Lymphoid Malignancies, and Solid Tumors. The solicitation requires 37 specific genetic probe products for human testing, with each probe designed to identify specific genetic mutations or chromosomal abnormalities. Proposals will be evaluated on three primary factors: Technical Capability, Price, and Salient Characteristics, with technical acceptability determined on an acceptable/unacceptable basis. Interested vendors must submit their proposals by May 2, 2025, at 9:00 AM Pacific Time via email to Carlos Magana, with the expectation of providing product brochures, warranty details, and potentially a dealer authorization letter.

The contract has no specific set-aside designation and will be conducted through full and open competition under NAICS Code 325413 for In-Vitro Diagnostic Substance Manufacturing. The period of performance is from May 9, 2025, to May 8, 2026, with orders to be made on an as-needed basis. The place of performance is the VA Greater Los Angeles Healthcare System West LA Campus, located at 11301 Wilshire Blvd, Los Angeles, CA 90073. The solicitation is specifically seeking Metasystems brand probes, with quantities ranging from 1 to 68 units per probe type, covering a comprehensive range of genetic and chromosomal diagnostic probes. Contractors must comply with strict information security protocols, including background investigations for personnel accessing VA computer systems and adherence to federal information security regulations like FISMA and NIST standards. Delivery will be FOB Destination, with all shipping costs included in the scheduled prices.